Related Experiment Video
Updated: Feb 7, 2026
05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
2.1K
Dose-ranging study of an orlistat tablet formulation.
Summary
Orlistat tablets effectively inhibit dietary fat absorption, with higher doses leading to increased fecal fat excretion. The 48-mg tablet showed similar efficacy to the 60-mg capsule.
Area of Science:
- Pharmacology
- Gastroenterology
Background:
- Orlistat is a lipase inhibitor used for obesity management.
- Understanding dose-response relationships for different formulations is crucial for optimizing treatment.
Purpose of the Study:
- To compare the efficacy of various doses of orlistat tablets in inhibiting dietary fat absorption against a standard orlistat capsule.
- To evaluate the dose-dependent effect of orlistat tablets on fecal fat excretion.
Main Methods:
- A randomized, open-label study involving 83 overweight/obese subjects.
- Subjects received one of six treatment arms: orlistat tablets (24, 36, 48, 72, 144 mg) or a 60-mg orlistat capsule.
- Fecal fat content was analyzed before and after treatment.
Main Results:
- The 48-mg orlistat tablet demonstrated comparable dietary fat absorption inhibition to the 60-mg orlistat capsule (mean fecal fat: 16.5% vs. 16.8%).
- A dose-dependent increase in fecal fat excretion was observed with orlistat tablets, with the 144-mg dose resulting in approximately 2.5 times greater excretion than the 24-mg dose.
- No new safety concerns were identified during the study.
Conclusions:
- Orlistat tablet efficacy in inhibiting dietary fat absorption is dose-dependent.
- Increasing the dose of orlistat tablets leads to a proportional increase in fecal fat excretion.
- The 48-mg orlistat tablet offers comparable efficacy to the 60-mg capsule.
Related Concept Videos
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
338
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
338
00:59Range
14.3K
The range is one of the measures of variation. It can be defined as the difference between a dataset's highest and lowest values. For example, in the study of seven 16-ounce soda cans, the filled volume of soda was measured, thus producing the following amount (in ounces) of soda:
15.9; 16.1; 15.2; 14.8; 15.8; 15.9; 16.0; 15.5
Measurements of the amount of soda in a 16-ounce can vary since different subjects record these measurements or since the exact amount - 16 ounces of liquid, was not...
15.9; 16.1; 15.2; 14.8; 15.8; 15.9; 16.0; 15.5
Measurements of the amount of soda in a 16-ounce can vary since different subjects record these measurements or since the exact amount - 16 ounces of liquid, was not...
14.3K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
249
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
249
01:27¹H NMR: Long-Range Coupling
2.7K
The coupling interactions of nuclei across four or more bonds are usually weak, with J values less than 1 Hz. While these are usually not observed in spectra, the presence of multiple bonds along the coupling pathway can result in observable long-range coupling.
In alkenes, spin information is communicated via σ–π overlap, as seen in allylic (four-bond) and homoallylic (five-bond) couplings. These coupling interactions are stronger when the σ bond is parallel to the alkene...
In alkenes, spin information is communicated via σ–π overlap, as seen in allylic (four-bond) and homoallylic (five-bond) couplings. These coupling interactions are stronger when the σ bond is parallel to the alkene...
2.7K
01:21Dose Size and Dosing Frequency: Determination Methods
312
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
312
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
246
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
246